CEACAM6 and breast neoplasm: The highly frequent over expression of PDEF and CEACAM6 in ER+ breast tumors prompted us to examine whether similar elevated co-expression of these molecules also occurs in Her2 over expressing (Her2+) and triple-negative breast tumors.